A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Head and Neck Cancer
- Hypopharynx Cancer
- Hypopharynx Squamous Cell Carcinoma
- Larynx Cancer
- Oral Cavity Cancer
- Oral Cavity Squamous Cell Carcinoma
- Oropharynx Cancer
- Oropharynx Squamous Cell Carcinoma
- Pharynx Cancer
- Squamous Cell Carcinoma of Head and Neck
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04892875
- Collaborators
- Arcus Biosciences, Inc.
- Investigators
- Principal Investigator: Jennifer Choe, MD, PhD Duke University